Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g Tablets, El(26)a/20
Recall Summary Doncaster Pharma Limited is recalling certain batches of Hiprex 1g tablets in the UK because the Braille labeling on the outer packaging is incorrect. These are parallel imported batches of the medication, which is a prescription-only medicine. The defect affects the Braille text used by blind or visually impaired patients to identify the medication.
- Recalling firm
- Doncaster Pharma Limited
- Reason
- Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2026-04-22
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/5b79842e-d618-4b48-8368-68fb76dbc5c0